Summit Securities Group’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-75,000
Closed -$1.09M 1101
2025
Q4
$1.09M Buy
75,000
+40,000
+114% +$697K 0.14% 123
2025
Q3
$628K Buy
35,000
+19,500
+126% +$286K 0.13% 150
2025
Q2
$265K Buy
15,500
+10,500
+210% +$105K 0.05% 201
2025
Q1
$36.2K Sell
5,000
-15,000
-75% -$171K 0.01% 374
2024
Q4
$281K Buy
+20,000
New +$295K 0.06% 168
2024
Q3
Sell
-500
Closed -$5.18K 628
2024
Q2
$5K Buy
+500
New +$2.55K ﹤0.01% 488

Other funds holding CORZ

Summit Securities Group's CORZ Position: Q1 2026 in Review

Summit Securities Group sold out of Core Scientific (CORZ) in Q1 2026, closing a stake of 75,000 shares — an estimated $1.09M sold.

Summit Securities Group first reported a position in CORZ in Q2 2024 and held it in 6 quarters. The position peaked at $1.09M in Q4 2025. 387 funds tracked by Wall St. Rank hold CORZ as of Q1 2026.

  • Summit Securities Group reported no remaining Core Scientific position as of Q1 2026 after selling out during the quarter.
  • Summit Securities Group sold 75,000 Core Scientific shares in Q1 2026, an estimated $1.09M.
  • Summit Securities Group first reported a position in Core Scientific in Q2 2024 and held it in 6 quarters.
  • Summit Securities Group's Core Scientific position peaked at $1.09M in Q4 2025.
  • 387 funds tracked by Wall St. Rank held Core Scientific as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.